dimethylformamide has been researched along with transforming growth factor beta in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dittrich, C; Dittrich, E; Ellinger, A; Grunt, TW; Pavelka, M; Somay, C | 1 |
| Dittrich, C; Grunt, TW; Mannhalter, C; Somay, C | 1 |
| Dittrich, C; Dittrich, E; Fazeny, B; Grunt, TW; Mannhalter, C; Oeller, H; Somay, C | 1 |
| Morris, SL; Mulder, KM; Ziober, BL; Zipfel, PA | 1 |
| Levine, AE; Lewis, LR | 1 |
5 other study(ies) available for dimethylformamide and transforming growth factor beta
| Article | Year |
|---|---|
The differential effects of N,N-dimethylformamide and transforming growth factor-beta 1 on a human ovarian cancer cell line (HOC-7).
Topics: Cell Division; Cytoskeletal Proteins; Desmoplakins; Dimethylformamide; DNA; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Fibronectins; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Immunophenotyping; Microscopy, Electron; Ovarian Neoplasms; Time Factors; Transforming Growth Factor beta; Tumor Cells, Cultured | 1992 |
Relationship of myc protein expression to the phenotype and to the growth potential of HOC-7 ovarian cancer cells.
Topics: Actins; Adenocarcinoma; Blotting, Western; Cell Differentiation; Cell Division; Cell Line; Dimethyl Sulfoxide; Dimethylformamide; Female; Fibronectins; Fluorescent Antibody Technique; Genes, myc; Humans; Ovarian Neoplasms; Phenotype; Proto-Oncogene Proteins c-myc; Transforming Growth Factor beta; Tretinoin | 1992 |
Modulation of the immunophenotype of ovarian cancer cells by N,N-dimethylformamide and transforming growth factor-beta 1.
Topics: Blotting, Western; Cytoskeletal Proteins; Desmoplakins; Dimethylformamide; Dose-Response Relationship, Drug; Down-Regulation; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Extracellular Matrix; Female; Fibronectins; Humans; Immunohistochemistry; Immunophenotyping; Ovarian Neoplasms; Radioimmunoassay; Transforming Growth Factor beta; Tumor Cells, Cultured | 1993 |
Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells.
Topics: Cell Differentiation; Cell Division; Colonic Neoplasms; Culture Media, Serum-Free; Dimethylformamide; Epidermal Growth Factor; Humans; Phenotype; RNA, Messenger; Transforming Growth Factor alpha; Transforming Growth Factor beta; Tumor Cells, Cultured; Up-Regulation | 1993 |
Transforming growth factor-beta 2 is an autocrine growth inhibitory factor for the MOSER human colon carcinoma cell line.
Topics: Antibodies; Cell Division; Colonic Neoplasms; Dimethylformamide; Growth Inhibitors; Humans; Transforming Growth Factor beta; Tumor Cells, Cultured | 1993 |